StonvexLoading…
StonvexStonvexStonvexCore line items from EMN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.18B | $8.75B | $6.78B | $4.58B |
Operating Income | $136.00M | $568.00M | $556.00M | $422.00M |
Net Income | $107.00M | $474.00M | $369.00M | $322.00M |
EPS (Diluted) | $0.93 | $4.10 | $3.18 | $2.77 |
Total Assets | $15.22B | $14.86B | $14.98B | $15.22B |
Total Liabilities | $9.14B | $8.82B | $9.14B | $9.31B |
Cash & Equivalents | $665.00M | $566.00M | $489.00M | $423.00M |
Free Cash Flow OCF − CapEx | $-240.00M | $424.00M | $34.00M | $-231.00M |
Shares Outstanding | 115.00M | 223.94M | 116.00M | 116.40M |